{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T02:11:26Z","timestamp":1792721486426,"version":"4.5.0"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["R01 EY027329"],"award-info":[{"award-number":["R01 EY027329"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jcrsjournal.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.jcrs.2019.04.020","type":"journal-article","created":{"date-parts":[[2019,8,20]],"date-time":"2019-08-20T21:34:45Z","timestamp":1566336885000},"page":"1498-1502","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Injection volume and intracameral moxifloxacin dose"],"prefix":"10.1097","volume":"45","author":[{"given":"Neal H.","family":"Shorstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Gardner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20-20210210","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/nrmicro862","article-title":"Antimicrobial pharmacodynamics: critical interactions of bug and drug.","volume":"2","author":"Drusano","year":"2004","journal-title":"Nat Rev Microbiol"},{"key":"R2-20-20210210","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1016\/j.jcrs.2007.06.026","article-title":"Perspectives on antibiotics for postoperative endophthalmitis prophylaxis: potential role of moxifloxacin.","volume":"33","author":"OBrien","year":"2007","journal-title":"J Cataract Refract Surg"},{"key":"R3-20-20210210","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ophtha.2015.09.037","article-title":"Efficacy of intracameral moxifloxacin endophthalmitis prophylaxis at Aravind Eye Hospital.","volume":"123","author":"Haripriya","year":"2016","journal-title":"Ophthalmology"},{"key":"R4-20-20210210","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ophtha.2015.08.039","article-title":"Comparative effectiveness of antibiotic prophylaxis in cataract surgery.","volume":"123","author":"Herrinton","year":"2016","journal-title":"Ophthalmology"},{"key":"R5-20-20210210","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.jcrs.2018.10.044","article-title":"Safety and efficacy of intracameral moxifloxacin for prevention of post-cataract endophthalmitis: randomized controlled clinical trial.","volume":"45","author":"Melega","year":"2019","journal-title":"J Cataract Refract Surg"},{"key":"R6-20-20210210","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/j.jcrs.2008.05.034","article-title":"Evaluation of the safety of prophylactic intracameral moxifloxacin in cataract surgery.","volume":"34","author":"Lane","year":"2008","journal-title":"J Cataract Refract Surg"},{"key":"R7-20-20210210","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/j.jcrs.2012.04.025","article-title":"Complication rates of phacoemulsification and manual small-incision cataract surgery at Aravind Eye Hospital.","volume":"38","author":"Haripriya","year":"2012","journal-title":"J Cataract Refract Surg"},{"key":"R8-20-20210210","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jcrs.2006.09.019","article-title":"Safety of prophylactic intracameral moxifloxacin 0.5 ophthalmic solution in cataract surgery patients.","volume":"33","author":"Espiritu","year":"2007","journal-title":"J Cataract Refract Surg"},{"key":"R10-20-20210210","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00417-012-2098-1","article-title":"Bag and chamber flushing: a new method of using intracameral moxifloxacin to irrigate the anterior chamber and the area behind the intraocular lens.","volume":"251","author":"Matsuura","year":"2013","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R11-20-20210210","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1016\/j.jcrs.2016.10.017","article-title":"Dose and administration of intracameral moxifloxacin for prophylaxis of postoperative endophthalmitis.","volume":"42","author":"Arshinoff","year":"2016","journal-title":"J Cataract Refract Surg"},{"key":"R12-20-20210210","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/archopht.1997.01100150167003","article-title":"Postoperative contamination after using vancomycin and gentamicin during phacoemulsification.","volume":"115","author":"Ferro","year":"1997","journal-title":"Arch Ophthalmol"},{"key":"R13-20-20210210","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/eye.1998.92","article-title":"The effect of intracameral, per-operative antibiotics on microbial contamination of anterior chamber aspirates during phacoemulsification.","volume":"12","author":"Beigi","year":"1998","journal-title":"Eye"},{"key":"R14-20-20210210","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.2147\/OPTH.S68370","article-title":"Clear-cornea cataract surgery: pupil size and shape changes, along with anterior chamber volume and depth changes. A Scheimpflug imaging study.","volume":"8","author":"Kanellopoulos","year":"2014","journal-title":"Clin Ophthalmol"},{"key":"R15-20-20210210","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.jcrs.2017.04.028","article-title":"Endophthalmitis prophylaxis by intracameral antibiotics: in vitro model comparing vancomycin, cefuroxime, and moxifloxacin.","volume":"43","author":"Libre","year":"2017","journal-title":"J Cataract Refract Surg"},{"key":"R16-20-20210210","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1007\/s00417-013-2294-7","article-title":"Comparison between intracameral moxifloxacin administration methods by assessing intraocular concentrations and drug kinetics.","volume":"251","author":"Matsuura","year":"2013","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R17-20-20210210","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1016\/j.jcrs.2014.08.027","article-title":"Comparison of toxicities of moxifloxacin, cefuroxime, and levofloxacin to corneal endothelial cells in vitro.","volume":"40","author":"Haruki","year":"2014","journal-title":"J Cataract Refract Surg"},{"key":"R18-20-20210210","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1097\/ICO.0000000000000967","article-title":"Toxicity of intracameral injection of fourth-generation fluoroquinolones on the corneal endothelium.","volume":"35","author":"e Silva","year":"2016","journal-title":"Cornea"},{"key":"R19-20-20210210","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1442-9071.2008.01771.x","article-title":"Comparison of the effect of intracameral moxifloxacin, levofloxacin and cefazolin on rabbit corneal endothelial cells.","volume":"36","author":"Kim","year":"2008","journal-title":"Clin Exp Ophthalmol"},{"key":"R20-20-20210210","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.ajo.2005.04.015","article-title":"Intracameral Vigamox (moxifloxacin 0.5) is non-toxic and effective in preventing endophthalmitis in a rabbit model.","volume":"140","author":"Kowalski","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"R21-20-20210210","doi-asserted-by":"crossref","first-page":"102","DOI":"10.7869\/djo.218","article-title":"Effect of intracameral moxifloxacin (0.5mg) on morphology and cell density of corneal endothelium in phacoemulsification surgery.","volume":"27","author":"Malik","year":"2016","journal-title":"Delhi J Ophthalmol"},{"key":"R22-20-20210210","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/j.ophtha.2015.04.036","article-title":"Characteristics of endophthalmitis after cataract surgery in the United States Medicare population.","volume":"122","author":"Gower","year":"2015","journal-title":"Ophthalmology"},{"key":"R23-20-20210210","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1016\/j.jcrs.2016.11.008","article-title":"Antibiotic susceptibility of bacterial pathogens isolated from the aqueous and vitreous humor in the Antibiotic Resistance Monitoring in Ocular Microorganisms (ARMOR) surveillance study.","volume":"42","author":"Asbell","year":"2016","journal-title":"J Cataract Refract Surg"},{"key":"R24-20-20210210","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/j.jcrs.2009.04.036","article-title":"Kill rates of preserved and preservative-free topical 8-methoxy fluoroquinolones against various strains of Staphylococcus.","volume":"35","author":"Hyon","year":"2009","journal-title":"J Cataract Refract Surg"},{"key":"R25-20-20210210","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.ajo.2006.06.006","article-title":"The in vitro impact of moxifloxacin and gatifloxacin concentration (0.5 vs 0.3) and the addition of benzalkonium chloride on antibacterial efficacy.","volume":"142","author":"Kowalski","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"R26-20-20210210","first-page":"3145","article-title":"Flow of aqueous humor in humans The Friedenwald Lecture.","volume":"32","author":"Brubaker","year":"1991","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R27-20-20210210","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1007\/s00417-012-2036-2","article-title":"Pharmacokinetics of subconjunctival injection of moxifloxacin in humans.","volume":"251","author":"Matsuura","year":"2013","journal-title":"letter, Grae Graefes Arch Clin Exp Ophthalmol"},{"key":"R28-20-20210210","doi-asserted-by":"crossref","first-page":"52","DOI":"10.2174\/1874364101004010052","article-title":"Aqueous humor dynamics: A review.","volume":"4","author":"Goel","year":"2010","journal-title":"Open Ophthalmol J"}],"container-title":["Journal of Cataract and Refractive Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0886335019303268?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0886335019303268?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/10.1016\/j.jcrs.2019.04.020","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,15]],"date-time":"2021-06-15T18:37:05Z","timestamp":1623782225000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1016\/j.jcrs.2019.04.020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":27,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1016\/j.jcrs.2019.04.020","relation":{},"ISSN":["0886-3350"],"issn-type":[{"value":"0886-3350","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Injection volume and intracameral moxifloxacin dose","name":"articletitle","label":"Article Title"},{"value":"Journal of Cataract & Refractive Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcrs.2019.04.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 ASCRS and ESCRS Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}